News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–18
Matches
18
Sources here
9
Companies here
1
Search results Stored financial headlines

Active search

18 matching headlines

Ticker or company: IMMPMain company stories
Clear
Latest

MarketBeat Market update

Short Interest in Prima BioMed Ltd (NASDAQ:IMMP) Declines By 44.4%

Short interest in Prima BioMed Ltd (NASDAQ:IMMP) significantly dropped by 44.4% in July, totaling 1,195,547 shares as of July 31st. This represents 0.8% of outstanding shares and a 5.4-day-to-cover ratio. While institutional ownership remains low at 2.32%, analyst sentiment is mixed, with a consensus "Hold" rating and a $5.50 target price, despite the stock trading near its 52-week …

Main company 🇺🇸 United States
Read at MarketBeat
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
TradingKey Earnings Main company 🇺🇸 United States

Immutep Ltd (IMMP) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Immutep Ltd (IMMP), detailing analyst ratings and price targets. Based on two analysts, the stock has a "Buy" rating with an average target price of $8.26, indicating a significant upside potential of over 1300%. The article also …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Immutep Ltd (IMMP) Stock News Today

This article provides a brief update on Immutep Ltd (IMMP) stock news. It states that more news will be coming soon regarding the company's earnings, analyst ratings, and key developments. The page also displays current stock information for IMMP, including its price, daily change, …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stock Titan Earnings Main company 🇺🇸 United States

Immutep (NASDAQ: IMMP) ends lung trial, extends cash runway

Immutep Limited (NASDAQ: IMMP) reported mixed Q4 FY26 results, discontinuing its Phase III TACTI-004 lung cancer trial due to futility but showing positive progress in other programs like INSIGHT-003 and IMP761. The company maintains strong liquidity with A$68.87 million in cash and cash equivalents, …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Immutep's IMP761 Shows Immune Activity in First-in-Human Trial

Immutep (NASDAQ: IMMP) released its Q4 FY26 activities report, detailing new clinical, intellectual property, and financial developments. Key highlights include positive pooled analysis from efti trials showing a 7.7-month median overall survival benefit for biological responders and promising first-in-human data for IMP761, which met …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Immutep Ltd (IMMP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article for Immutep Ltd (IMMP) concerns the company's revenue breakdown by business segments and regional contributions. However, it explicitly states that the relevant data for these breakdowns has not been disclosed by the company yet. Therefore, the article provides no specific financial details …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Immutep Ltd Sponsored ADR Revenue Breakdown – FWB:YP1A

The article provides a financial overview and market data for Immutep Ltd Sponsored ADR (FWB:YP1A) on the Frankfurt Stock Exchange. It highlights the company's financial statements, statistics, dividends, earnings, and segments, indicating a focus on its fundamental performance. No specific revenue breakdown figures are …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

IMMP|Immutep Ltd|Price:0.385|Chg%:-0.008

This article provides an overview of Immutep Ltd (IMMP) with its current stock price and change percentage. It details how TradingKey generates its stock scores, covering dimensions like financial health, company valuation, earnings forecasts, price momentum, institutional confidence, and risk management. However, it notes …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Immutep Ltd (IMMP) Institutional Confidence

The article provides an overview of Immutep Ltd's (IMMP) institutional confidence based on shareholding data. It lists several institutional investors, their shareholdings, and the percentage change in their positions. Key investors include BlackRock Institutional Trust Company, N.A., UBS Financial Services, Inc., and Millennium Management …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Immutep Ltd Revenue Breakdown – SWB:YP1B

The article provides a revenue breakdown for Immutep Ltd (SWB:YP1B) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segment performance. The page also prominently displays various navigation elements and links to TradingView's extensive features and community …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Capital return Main company 🇺🇸 United States

Immutep Ltd (IMMP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Immutep Ltd (IMMP). It indicates that Immutep Ltd has distributed a total of $0.00 in dividends over the past 5 years and currently has no data available for dividend dates. The article also includes …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Immutep Ltd (IMMP) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Immutep Ltd (IMMP), detailing its stock performance and key financial metrics like Market Cap. It notes that relevant data for P/E, P/B, P/S, and P/CF ratios have not yet been disclosed by the company. The overview includes …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Immutep Ltd (IMMP) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Immutep Ltd (IMMP), detailing its volatility, financial risk, and investment risk metrics. Key data points include beta, VaR, maximum drawdown, and various volatility and liquidity measures over different periods. The information is intended to help investors understand …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Market update Main company 🇺🇸 United States

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Immutep Limited announced that an abstract for its investigator-initiated EFTISARC-NEO Phase II trial has been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2026. The abstract will report health-related quality of life (HRQoL) data from the trial, which evaluates eftilagimod …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Kalkine Media Market update Main company 🇺🇸 United States

Immutep's Eftilagimod Alfa Quality of Life Findings Approved for ESMO Congress 2026 in Madrid

Immutep Limited (ASX: IMM; NASDAQ: IMMP) announced that an abstract detailing health-related quality of life outcomes from its EFTISARC-NEO Phase II trial has been accepted for presentation at the ESMO Congress 2026 in Madrid. The trial investigates eftilagimod alfa in combination with pembrolizumab and …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Kalkine Market update Main company 🇺🇸 United States

Immutep's Eftilagimod Alfa Quality of Life Data Accepted for ESMO Congress 2026 Presentation

Immutep Limited announced that its abstract on health-related quality of life outcomes from the EFTISARC-NEO Phase II trial has been accepted for presentation at the ESMO Congress 2026 in Madrid. This trial evaluates eftilagimod alfa, a first-in-class MHC Class II agonist, in combination with …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sharecafe Earnings Main company 🇺🇸 United States

Immutep highlights encouraging survival data and key clinical milestones

Immutep (ASX: IMM; Nasdaq: IMMP) CEO Marc Voigt discussed positive overall survival data from the INSIGHT-003 trial, where patients achieved over 30 months of median overall survival. He also provided an update on the ongoing root cause analysis for the TACTI-004 Phase III trial …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context